Proanthocyanidins prevent tau protein aggregation and disintegrate tau filaments

doi:10.1016/j.cjche.2022.09.013

Abstract

Abstract: Occurrence of neurofibrillary tangles of the tau protein is a hallmark of tau-related neurodegenerative diseases, i.e. Alzheimer's disease (AD) and frontotemporal dementia. The pathological mechanism underlying AD remains poorly understood, and effective treatments are still unavailable to mitigate the disease. Inhibiting of tau aggregation and disrupting the existing fibrils are key targets in drug discovery towards preventing or curing AD. In this study, grape seed proanthocyanidins (GSPs) was found to effectively inhibit the repeat domain of tau (tau-RD) aggregation and disaggregate tau-RD fibrils in a concentration-dependent manner by inhibiting β-sheet formation of tau-RD. In cells, GSPs relieved cytotoxicity induced by tau-RD aggregates. Molecular dynamics simulations indicated that strong hydrogen bonding, hydrophobic interaction and π-π stacking between GSPs and tau-RD protein were major reasons why GSPs had high inhibitory activity on tau-RD fibrillogenesis. These results provide preliminary data to develop GSPs into medicines, foodstuffs or nutritional supplements for AD patients, suggesting that GSPs could be a candidate molecule in the drug design for AD therapeutics.

Key words: Protein, Aggregation, Disaggregation, Molecular simulation, Proanthocyanidins, Alzheimer’s disease (AD)

摘要： Occurrence of neurofibrillary tangles of the tau protein is a hallmark of tau-related neurodegenerative diseases, i.e. Alzheimer's disease (AD) and frontotemporal dementia. The pathological mechanism underlying AD remains poorly understood, and effective treatments are still unavailable to mitigate the disease. Inhibiting of tau aggregation and disrupting the existing fibrils are key targets in drug discovery towards preventing or curing AD. In this study, grape seed proanthocyanidins (GSPs) was found to effectively inhibit the repeat domain of tau (tau-RD) aggregation and disaggregate tau-RD fibrils in a concentration-dependent manner by inhibiting β-sheet formation of tau-RD. In cells, GSPs relieved cytotoxicity induced by tau-RD aggregates. Molecular dynamics simulations indicated that strong hydrogen bonding, hydrophobic interaction and π-π stacking between GSPs and tau-RD protein were major reasons why GSPs had high inhibitory activity on tau-RD fibrillogenesis. These results provide preliminary data to develop GSPs into medicines, foodstuffs or nutritional supplements for AD patients, suggesting that GSPs could be a candidate molecule in the drug design for AD therapeutics.

关键词: Protein, Aggregation, Disaggregation, Molecular simulation, Proanthocyanidins, Alzheimer’s disease (AD)

Huan-Huan Yin, Yin-Lei Han, Xiao Yan, Yi-Xin Guan. Proanthocyanidins prevent tau protein aggregation and disintegrate tau filaments[J]. Chinese Journal of Chemical Engineering, 2023, 57(5): 63-71.

Huan-Huan Yin, Yin-Lei Han, Xiao Yan, Yi-Xin Guan. Proanthocyanidins prevent tau protein aggregation and disintegrate tau filaments[J]. 中国化学工程学报, 2023, 57(5): 63-71.

References

[1] G.K. Viswanathan, D. Shwartz, Y. Losev, E. Arad, C. Shemesh, E. Pichinuk, H. Engel, A. Raveh, R. Jelinek, I. Cooper, F. Gosselet, E. Gazit, D. Segal, Purpurin modulates tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model, Cell Mol. Life Sci. 77 (14) (2020) 2795-2813.
[2] R. Leon, A.G. Garcia, J. Marco-Contelles, Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease, Med. Res. Rev. 33 (1) (2013) 139-189.
[3] Y. Liang, W. Wang, Y. Sun, X. Dong, Insights into the cross-amyloid aggregation of Aβ₄₀ and its N-terminal truncated peptide Aβ_11-40 affected by epigallocatechin gallate, Chinese J. Chem. Eng. 45 (2022) 284-293.
[4] L. Kruger, E.M. Mandelkow, Tau neurotoxicity and rescue in animal models of human tauopathies, Curr. Opin. Neurobiol. 36 (2016) 52-58.
[5] Y. Wang, E. Mandelkow, Tau in physiology and pathology, Nat. Rev. Neurosci. 17 (2016) 22-35.
[6] Y. Zhang, Y. Tang, D. Zhang, Y. Liu, J. He, Y. Chang, J. Zheng, Amyloid cross-seeding between Aβ and hIAPP in relation to the pathogenesis of Alzheimer and type 2 diabetes, Chinese J. Chem. Eng. 30 (2021) 225-235.
[7] E.H. Kellogg, N.M.A. Hejab, S. Poepsel, K.H. Downing, F. DiMaio, E. Nogales, Near-atomic model of microtubule-tau interactions, Science 360 (6394) (2018) 1242-1246.
[8] H.L. Liu, H.Y. Zhong, Z.R. Xu, Q.Q. Zhang, S.J.A. Shah, H.X. Liu, X.J. Yao, The misfolding mechanism of the key fragment R3 of tau protein: a combined molecular dynamics simulation and Markov state model study, Phys. Chem. Chem. Phys. 22 (19) (2020) 10968-10980.
[9] H. Kadavath, M. Jaremko, A. Jaremko, J. Biernat, E. Mandelkow, M. Zweckstetter, Folding of the tau protein on microtubules, Angew. Chem. Int. Ed. 54 (35) (2015) 10347-10351.
[10] L. Rani, J. Mittal, S.S. Mallajosyula, Effect of phosphorylation and O-GlcNAcylation on proline-rich domains of tau, J. Phys. Chem. B 124 (10) (2020) 1909-1918.
[11] A.V. Rojas, G.G. Maisuradze, H.A. Scheraga, Dependence of the formation of tau and Aβ peptide mixed aggregates on the secondary structure of the N-terminal region of Aβ, J. Phys. Chem. B 122 (28) (2018) 7049-7056.
[12] M.N.N. Vieira, L.F. Germano, L.M.F. Saraiva, A. Sebollela, A.M. Martinez, J.C. Houzel, F.G.D. Felice, S.T. Ferreira, Soluble oligomers from a non-disease related protein mimic Aβ-induced tau hyperphosphorylation and neurodegeneration, Neurochem. 103 (2) (2007) 736-748.
[13] K. Leroy, A. Bretteville, K. Schindowski, E. Gilissen, M. Authelet, R.D.Z. Decker, Z. Yilmaz, L. Buee, J.P. Brion, Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice, Am. J. Pathol. 171 (3) (2007) 976-992.
[14] C. Ballatore, J.Q. Trojanowski, Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders, Nat. Rev. Neurosci. 8 (9) (2007) 663–672.
[15] K. Iqbal, F. Liu, C. Gong, Tau and neurodegenerative disease: the story so far, Nat. Rev. Neurol. 12 (1) (2016) 15-27.
[16] B. Falcon, W.J. Zhang, A.G. Murzin, G. Murshudov, H.J. Garringer, R. Vidal, R.A. Crowther, B. Ghetti, S.H.W. Scheres, M. Goedert, Structures of filaments from Pick’s disease reveal a novel tau protein fold, Nature 561 (7721) (2018) 137-140.
[17] B. Falcon, J. Zivanov, W. Zhang, A.G. Murzin, H.J. Garringer, R. Vidal, R.A. Crowther, K.L. Newell, B. Ghetti, M. Goedert, S.H.W. Scheres, Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules, Nature 568 (7752) (2019) 420-423.
[18] J.S. Rane, P. Bhaumik, D. Panda, Curcumin inhibits tau aggregation and disintegrates preformed tau filaments in vitro, J. Alzheimers Dis. 60 (3) (2017) 999-1014.
[19] H.J. Wobst, A. Sharma, M.I. Diamond, E.E. Wanker, J. Bieschke, The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios, FEBS. Lett. 589 (1) (2015) 77-83.
[20] R.A. Rifaai, S.A. Mokhemer, E.A. Saber, S.A.A. El-Aleem, N.F.G. El-Tahawy, Neuroprotective effect of quercetin nanoparticles: a possible prophylactic and therapeutic role in Alzheimer’s disease, J. Chem. Neuroanat. 107 (2020) 101795.
[21] Z. Zhou, Y.Q. Gu, H.X. Wang, Artificial chiral interfaces against amyloid-β peptide aggregation: Research progress and challenges, ACS. Chem. Neurosci. 12 (22) (2021) 4236-4248.
[22] T. Lee, H. Kwon, B. Bang, Y.S. Lee, M. Park, K. Moon, T. Kim, K. Lee, H. Moon, Y.S. Cho, Grape seed proanthocyanidin extract attenuates allergic inflammation in murine models of asthma, J. Clin. Immunol. 32 (6) (2012) 1292-1304.
[23] Z. Zdunczyk, S. Frejnagel, M. Wróblewska, J. Juśkiewicz, J. Oszmiański, I. Estrella, Biological activity of polyphenol extracts from different plant sources, Food Res. Int. 35 (2-3) (2002) 183-186.
[24] B.M.S. Erben, H.S. Benjamin, M.D. Lau, Pycnogenol inhibits generation of inflammatory mediators in macrophages, Nutr. Res. 20 (2) (2000) 249-259.
[25] W.G. Li, X.Y. Zhang, Y.J. Wu, X. Tian, Anti-inflammatory effect and mechanism of proanthocyanidins from grape seeds, Acta. Pharmacol. Sin. 22 (12) (2001) 1117-1120.
[26] Y. Ding, X.Q. Dai, Z.F. Zhang, Y.F. Jiang, X.T. Ma, X.X. Cai, Y. Li, Proanthocyanidins protect against early diabetic peripheral neuropathy by modulating endoplasmic reticulum stress, J. Nutr. Biochem. 25 (7) (2014) 765-772.
[27] C.M. Liu, J.Q. Ma, S.S. Liu, G.H. Zheng, Z.J. Feng, J.M. Sun, Proanthocyanidins improves lead-induced cognitive impairments by blocking endoplasmic reticulum stress and nuclear factor-κB-mediated inflammatory pathways in rats, Food Chem. Toxicol. 72 (2014) 295-302.
[28] S.S. Zhou, H.L. Zou, C.J. Liu, M.J. Zang, T. Liu, Combining deep neural networks for protein secondary structure prediction, IEEE Access 8 (2020) 84362-84370.
[29] X. Li, T. Dai, P. Hu, C. Zhang, J. Chen, C. Liu, T. Li, Characterization the non-covalent interactions between beta lactoglobulin and selected phenolic acids, Food Hydrocoll. 105 (2020) 105761.
[30] K. Sarkar, S. Sarkar, R.K. Das, Screening of drug efficacy of rosmarinic acid derivatives as aurora kinase inhibitors by computer-aided drug design method, Curr. Comput-Aid. Drug Design 17 (5) (2021) 627-646.
[31] C.I. Bayly, P. Cieplak, W. Cornell, P.A. Kollman, A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model, J. Phys. Chem. 97 (40) (1993) 10269-10280.
[32] J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, D.A. Case, Development and testing of a general amber force field, J. Comput. Chem. 25 (9) (2004) 1157-1174.
[33] J.A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K.E. Hauser, C. Simmerling, ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB, J. Chem. Theory Comput. 11 (8) (2015) 3696-3713.
[34] B. Hess, P-LINCS: A parallel linear constraint solver for molecular simulation, J. Chem. Theory Comput. 4 (1) (2008) 116-122.
[35] G. Bussi, D. Donadio, M. Parrinello, Canonical sampling through velocity rescaling, J. Chem. Phys. 126 (1) (2007) 14101.
[36] M.J. Abraham, T. Murtola, R. Schulz, S. Páll, J.C. Smith, B. Hess, E. Lindahl, GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers, SoftwareX 1-2 (2015) 19-25.
[37] M.F. Adasme, K.L. Linnemann, S.N. Bolz, F. Kaiser, S. Salentin, V.J. Haupt, M. Schroeder, PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA, Nucleic Acids Res. 49 (W1) (2021) 530-534.
[38] J. Zhao, I. Huvent, G. Lippens, D. Eliezer, A. Zhang, Q.H. Li, P. Tessier, R.J. Linhardt, F.M. Zhang, C.Y. Wang, Glycan determinants of heparin-tau interaction, Biophys. 112 (5) (2017) 921-932.
[39] Y. Tu, S. Ma, F. Liu, Y. Sun, X. Dong, Hematoxylin inhibits amyloid β-protein fibrillation and alleviates amyloid-induced cytotoxicity, J. Phys. Chem. B 120 (4) (2016) 11360-11368.
[40] K. Bhattacharya, K.B. Rank, D.B. Evens, S.K. Sharma, Role of cysteine-291 and cysteine-322 in the polymerization of human tau into Alzheimer-like filaments, Biochem. Bioph. Res. Co. 285 (1) (2001) 20-26.
[41] M.H. Zhang, Q.P. Wu, X.B. Yao, J.Y. Zhao, W.C. Zhong, Q. Liu, S.F. Xiao, Xanthohumol inhibits tau protein aggregation and protects cells against tau aggregates, Food Funct. 10 (12) (2019) 7865-7874
[42] S. Shimonaka, S.E. Matsumoto, M. Elahi, K. Ishiguro, M. Hasegawa, N. Hattori, Y. Motoi, Asparagine residue 368 is involved in Alzheimer’s disease, J. Biol. Chem. 295 (41) (2020) 13996-14014.
[43] V.G. KrishnaKumar, A. Paul, E. Gazit, D. Segal, Mechanistic insights into remodeled tau-derived PHF6 peptide fibrils by naphthoquinone-tryptophan hybrids, Sci. Rep. 8 (2018) 71.